E Fund Management (Hong Kong) Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
E Fund Management (Hong Kong) Co., Ltd.
- $109 Million
- Q1 2025
A detailed history of E Fund Management (Hong Kong) Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, E Fund Management (Hong Kong) Co., Ltd. holds 40 shares of REGN stock, worth $23,990. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40
Previous 9
344.44%
Holding current value
$23,990
Previous $6,000
316.67%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,485Shares Held
87MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.57 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.07 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.23 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.9 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.84 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...